Where our team of guest writers discuss what they think about the current NGP US Issues.
Outsourcing providers have every reason to be happy. With an increasing volume of new drugs entering the clinical trial pipeline, the usage occasions for contract services are up.
With GlaxoSmithKline’s David Pulman, President, Global Manufacturing & Supply.
Mark Matzopoulos, a director of modeling technology company Process Systems Enterprise, takes a look at how modeling can revolutionize pharmaceutical companies’ understanding and thus design and operation of their processes.
Pharmaceutical companies are under increasing pressure to develop a greater understanding of their processes, both from commercial drivers and because of the new opportunities for process improvement opened up by Process Analytical Technology.
The TCP Panel reduces overall package size and weight